News Channels

18 Aug 2018 Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial
18 Aug 2018 FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
18 Aug 2018 HitGen Announces Innovative Drug Discovery Research Collaboration with LG Chem by Applying DNA-Encoded Technology
18 Aug 2018 Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study
17 Aug 2018 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung Cancer
17 Aug 2018 Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins
17 Aug 2018 Eisai and Merck Announce FDA Approval of LENVIMA® (lenvatinib) Capsules for First-line Treatment of Unresectable Hepatocellular Carcinoma (HCC)
16 Aug 2018 Eureka Therapeutics Announces Publication of Armored T-Cell Proof-of-Concept Study in Nature Biotechnology
16 Aug 2018 Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
16 Aug 2018 Sirnaomics Oncology IND Receives Green Light from US FDA to Initiate Study for Treatment of Cholangiocarcinoma
16 Aug 2018 Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center
16 Aug 2018 Inovio Treats First Patient in Immuno-Oncology Study for Advanced or Metastatic Bladder Cancer in Combination with Roche/Genentech’s Atezolizumab
16 Aug 2018 Ebola successfully neutralized by latest generation polyclonal immunotherapy
16 Aug 2018 Biohaven Reports Positive Results From Double-Blind, Placebo-Controlled, Investigator Initiated, Proof Of Concept Trial Of BHV-0223 For Anxiety
16 Aug 2018 Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease
16 Aug 2018 FDA Approves KALYDECO® (ivacaftor) as First and Only Medicine to Treat the Underlying Cause of CF in Children Ages 12 to less than 24 Months with Certain Mutations in the CFTR Gene
16 Aug 2018 BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
15 Aug 2018 Oragenics, Inc. Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review
15 Aug 2018 Leadiant Biosciences to Collaborate with National Institutes of Health on Therapy in Late-Stage Development for GNE Myopathy
15 Aug 2018 RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality and Persistence of T Cells and NK Cells for the Advancement of Immuno-Oncology Therapeutics for Solid Tumors

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up